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Abstract: Introduction: Facial nerve schwannoma is a rare benign tumor which may 
originate from any segment of the facial nerve. We present a case of a giant cystic facial 
nerve schwannoma that showed extension to the middle cerebral fossa, together with its 
clinical and radiological characteristics, and a short review of the related literature.  
Case Report: A 52-year old female patient attended with complaints of numbness in the 
right half of her face, and mild hearing loss. Examinations revealed House-Brackmann 
Grade 3 peripheral facial paralysis, sensorineural hearing loss of 30% in her right ear. She 
described three episodes of facial paralysis in the last six years. Cranial MRI and CT scan 
revealed a round cystic lesion of about 40x44x38 mm, located centrally and medially in 
the right temporal area. The surgical operation was performed and the lesion was totally 
extracted. The histopathological investigation reported the lesion as a schwannoma. 
Conclusion: Facial nerve schwannoma is a rare, benign tumor that occurs in different 
localizations. It may commonly be mistaken in prediagnosis and may be confused with 
other clinical states due to its clinical characteristics. It has to be kept in mind in the 
prediagnosis of patients with facial paresis and hearing loss.   
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Introduction 
Facial nerve schwannoma (FNS) is a 
benign tumor that is rarely seen, and is 
generally difficult to diagnose before surgery. 
It may originate from any segment of the facial 
nerve through its extension from its origin in 
the cerebellopontine angle, to the parotid 
gland. Schwannomas account for 8% of all 
intracranial tumors. Of these, FNSs account 
for about 1.9%. FNSs that extend to the middle 
cerebral fossa are rare, as they commonly 
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originate from the geniculate fossa (9, 10). 
Here, we present a case of a giant cystic facial 
nerve schwannoma that showed extension to 
the middle cerebral fossa, together with its 
clinical and radiological characteristics, and a 
review of the related literature.   
Case 
A 52-year old female patient attended with 
complaints of numbness in the right half of her 
face, and mild hearing loss. Her physical 
examination revealed House-Brackmann 
Grade 3 peripheral facial paralysis, and 
hearing loss. The audiometric evaluation 
revealed a sensorineural hearing loss of 30% in 
her right ear.  In her anamnesis, the patient 
described three episodes of facial paralysis: the 
first one occurred six years previously, the 
second four years, and the most recent one 15 
days previously; a radiological investigation 
had not been performed. Cranial contrast 
enhanced magnetic resonance imaging (MRI), 
revealed a round cystic lesion of about 
40x44x38 mm with regular margin, and with a 
peripheral capsule of about 8 mm maximal 
thickness, located centrally and medially in the 
right temporal area (Figure 1). In the 
computerized tomography (CT), we observed 
erosion of the petrous bone and widening in 
the facial hiatus on the right side (Figure 2). 
The patient was operated with a pre-diagnosis 
of meningioma, metastasis or schwannoma. 
The tumor was accessed using a right pterional 
craniotomy and sylvian dissection. The tumor 
was grey-yellow colored and it has 
hemorrhages in some areas. The tumor was 
easily dissected from the surrounding tissue. A 
tissue specimen was transferred for frozen 
section investigation. The pathological 
examination excluded malignancy. The mass 
was totally extracted following internal 
decompression. The optic nerve, carotid 
cisterns, and anterior communicating artery 
and its segments were intact. It was established 
that the petrous bone and dura were eroded in 
the area where the mass was adjacent to the 
temporal bone; therefore the dura was 
repaired in this region using a galeal graft, and 
the operation was completed. The 
histopathological investigation reported a 
schwannoma from the palisading pattern with 
S-100 protein positive, glial fibrillary acidic 
protein (GFAP) and epithelial membrane 
antigen (EMA) negative (Figures 3A,B). 
A post-operative physical examination of 
the patient revealed progression of right facial 
paralysis to House Brackmann Grade 4 level; 
her hearing loss was also determined to 
progress. An investigation of the facial nerve 
electromyography (EMG) revealed severe 
axonal damage in the facial nerve. A control 
EMG was recommended one month later. 
Almost complete hearing loss was determined 
on the right side in her audiometric evaluation. 
In the post-operative contrast enhanced 
cranial MRI, it was determined that the mass 
has been totally excised (Figure 4).  The patient 
was discharged from hospital on the post-
operative 14th day. The second control EMG 
was administered about two months later, and 
the result was compatible with a lesion causing 
complete axonal damage to the right facial 
nerve segments that branches off from the 
orbicularis oculi and frontal muscles, and 
severe axonal damage in the segment that 
branches off from the orbicularis oris muscle.
 
 
 
 
 
Romanian Neurosurgery (2018) XXXII 4: 625 - 631 | 627 
 
 
 
 
 
 
 
 
Figure 1 - Contrast enhanced cranial MRI: A round cystic lesion of 40x44x38 mm in size with a regular margin, 
and with a peripheral capsule of 8 mm in maximal thickness, located centrally and medially in the right temporal 
lobe. A: Axial section. B: Coronal section 
 
 
Figure 2 - A: Widening and erosion in the facial hiatus in axial section, in the temporal CT. B: Erosion in the right 
temporal bone petrous segment, in the coronal section 
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Figure 3 - A: Bundles of fusiform cells by hematoxylin staining, magnified 100 times. B: Diffuse positive reaction 
by S-100 immunohistochemical staining 
 
 
Figure 4 - Postoperative changes in the postoperative contrast enhanced cranial MRI 
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Discussion 
Schwannomas are simply benign tumors 
that originate from the Schwann sheaths of the 
peripheral neural cells (cranial and spinal). 
Giant size described as > 4.0 cm in maximal 
extrameatal diameter by Samii et al. (7). They 
arise from sensory nerves, and are also known 
as neuromas. Schwannomas that originate 
from cranial nerves account for 8% of 
intracranial tumors, and they occur at a 
relatively high frequency. FNS accounts for 
1.9% of all intracranial tumors. A FNS 
generally extends intracranially to the 
cerebellopontine angle, and to a lesser extent, 
to the middle cerebral fossa (11). Its rare 
occurrence in middle cerebral fossa, and the 
presence of more frequently seen lesions in 
this area that have similar appearances 
radiologically, make the differential diagnosis 
and accurate pre-diagnosis difficult. 
FNS occurs clinically as a facial nerve 
paresis or paralysis with a long-lasting, 
fluctuating and progressive course. It has to be 
kept in mind that hearing loss (sensorineural 
or conductive type) occurs as frequently as 
facial paralysis. It has found to occur even 
more frequently in some studies, including 
large case series (4). This clinical feature often 
leads to false pre-diagnosis of vestibular 
schwannoma. Symptoms are often found to be 
associated within the region of the facial nerve 
in which the lesion is located. The symptoms 
are generally characterized with various 
distributions of the facial, otologic, and mass 
effect signs; however this is not a clinically 
pathognomonic sign for the diagnosis of FNS. 
A high correlation has been detected between 
the degree of facial nerve dysfunction and 
intratemporal location; otologic complaints 
like sensorineural hearing loss, tinnitus, and 
vertigo have been reported most frequently in 
patients with intracranial tumors (2). Because 
the differential diagnosis of acoustic neuroma 
and FNS is difficult, diagnosis of FNS is almost 
always ascertained perioperatively or 
postoperatively.  
There are different studies and 
classifications related to the localization and 
frequency of FNSs on the facial nerve. In many 
studies, it has been reported that FNS most 
frequently occurs in the geniculate ganglion 
along the course of the facial nerve (4). In a 
study comprising 24 patients with a 
histopathological diagnosis of FNS, the facial 
nerve has been investigated in eight separated 
segments, as follows: cerebellopontine angle, 
internal acoustic canal, labyrinth, geniculate 
fossa, nervus petrosus major, tympanic, 
mastoid, and intracranial. In this study, the 
geniculate fossa was established to be the most 
frequent location (83%); of these tumors 
located in the geniculate fossa, 60% occurred 
with extension to the labyrinth, and 30% were 
with petrosal nerve involvement. Only two 
cases were determined with intracranial 
extension (8.3%), and both of these originated 
from the geniculate fossa. Facial neuropathy 
was identified in these two cases with 
intracranial extension, and one case with 
sensorineural hearing loss (11). In a study, the 
location of FNS was classified as 
intratemporal, extratemporal and intracranial, 
and the most frequent location was in the 
intratemporal region (61%); tumors with 
extratemporal (parotid area) and intracranial 
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(cerebellopontine angle) locations, were 
reported in equal frequencies. In this study, 
extension to the middle cerebral fossa was not 
included in the intracranial location, and one 
tumor was reported with intracranial 
extension occurred in the intratemporal 
location (2). 
High-resolution enhanced CT and MRI, 
are the most important visualization methods 
in the radiological diagnosis of FNS. CT may 
not be considered absolutely essential; 
however it is important in the visualization of 
the changes in the temporal bone, to 
determine the origin of the tumor, and when 
planning surgery. Erosion of the petrous bone, 
internal acoustic canal and a widened facial 
hiatus can easily be visualized using CT, which 
also helps in the preoperative differential 
diagnosis (8). An contrast enhanced MRI is the 
preferential diagnosis for FNS, independent of 
the size and location of the tumor. These 
tumors classically occur in MR imaging as 
hypo-hyperintense in the T1 weighted 
sequences, hyperintense in the T2 weighted 
sequences, and with contrast enhancement 
(3). Large tumors commonly show cystic 
differentiation, and peripheral contrast 
enhancement.  
FNSs with extension to the middle cerebral 
fossa, are benign tumors, and they frequently 
cause mass effect; the first choice of treatment 
is therefore surgery. Different studies make 
different recommendations regarding the 
surgical indication and approach; however the 
most common suggestion for tumors beyond 
House-Brackmann stage 3, is surgery (4). 
FNSs are tumors that grow very slowly (0.02 
cm3 /year); however surgery must not be 
delayed when there is involvement of the 
middle fossa (6). Taking into consideration the 
sense of hearing, and location of the tumor in 
the facial nerve segment, suboccipital, 
infratemporal, frontotemporal, transpetrosal, 
and retrosigmoid approaches may be 
undertaken by neurosurgeons, with the 
participation of nose-ear-throat specialists, if 
needed. FNSs are tumors of the nerve sheath, 
and it is theoretically possible to extract them 
without damaging the nerve; however 
following middle fossa surgery, this segment of 
the facial nerve is almost always extracted 
together with the tumor. This results in 
permanent facial paralysis. There are studies in 
the literature using different methods of 
reconstruction; however nerve function better 
than that of House-Brackmann stage 3 cannot 
be maintained (2, 5). The general methods 
applied include the interposition of the nervus 
auricularis major, and hypoglossal nerve 
anastomosis by grafts from the sural nerve or 
vestibular nerve. Additional techniques 
including sutures and fibrin tissue adhesives 
without sutures are also used. Facial nerve 
conduction can be maintained in some of 
these studies; however clinical improvement 
does not occur, due to atrophy developing in 
the muscles that it innervates. In cases with 
unimpaired hearing occurring with tumors 
extending to the middle cerebral fossa, 
transmastoid- middle fossa combined surgery 
is recommended. Hearing may be maintained 
to some extent following surgery, in small or 
moderate tumors (3-15 mm); in large tumors 
(>18 mm), but it has also been reported that 
it’s not possible to protect the sense of hearing 
(1).  
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Conclusion 
Facial nerve schwannoma is a rare, benign 
tumor that occurs in different localizations. It 
may commonly be mistaken in prediagnosis, 
and may be confused with other clinical states 
due to its clinical characteristics. It is possible 
to protect the sense of hearing, and the facial 
nerve functions in cases diagnosed at an early 
stage; therefore it has to be kept in mind in the 
differential diagnosis of patients with facial 
paresis and hearing loss.  
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